Cipla share news and announcements
NSE: CIPLABSE: 500087Pharmaceuticals & BiotechnologyLarge Cap
Last close ₹1,338.00up ₹7.10 (0.53%)BSE ₹1,337.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,330.90.
52-week range of traded prices to 23 Oct 2026
₹1,165.70Low, 2 Apr 2026₹1,673.00High, 23 Oct 2025
- Next results date: the board meets on 27 Oct 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹1,08,093 Cr99th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 32.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 13 May 2026
- 3.1
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.97%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 10.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 11.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 13 May 2026
- 0.01
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 13,23,90058.1% delivered
Cipla share news and announcements
1,573 announcements, routine notices left out, newest first. Page 31 of 32.
Oct 2009
28 Oct · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 137118 lacs for quarter ending on 30-SEP-2009 against Rs. 130246 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 27574 lacs for the quarter ending on 30-SEP-2009 against Rs. 15143 lacs for the quarter ending on 30-SEP-2008.20 Oct · Board meeting
Meeting on 28 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Sep 2009
29 Sep · Business
Cipla Ltd. has informed the Exchange that "The duly authorized Committee of Directors of the Company at its meeting held today i.e. on September 29, 2009 , at Hyderabad has issued and allotted 2,56,30,000 fully paid-up equity Shares of Rs. 2 each ("Equity Share") at an issue price of Rs.263.75 per Equity Share (including a premium of Rs.261.75 per Equity Share) aggregating to Rs.6,75,99,12,500 to qualified institutional bidders by way of a qualified institutions placement in terms of Chapter VIII of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2009".25 Sep · Business
Cipla Ltd. has informed the Exchange that "The duly authorized Committee of Directors of the Company at its meeting held today i.e. on September 24, 2009 has decided to close the bid period and has approved issuance of 2,56,30,000 Equity Shares of Rs. 2 each of the Company at a price of Rs. 263.75 per Equity Share (including a premium of Rs. 261.75 per equity share) under the QIP issue, aggregating to Rs. 6,75,99,12,500/-. The Committee has also approved the Placement Document in respect of the Equity Shares proposed to be issued as aforesaid."
Aug 2009
28 Aug · Meeting
Cipla Ltd. has informed the Exchange that at the Annual General Meeting of the Members of the Company held on August 26, 2009 all resolutions (as per attachment) were passed unanimously. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements) For more details click here.13 Aug · Meeting
Cipla Ltd. has informed the Exchange that the Annual General Meeting of the members of the Company will be held on August 26, 2009.
Jul 2009
29 Jul · Updates
Cipla Ltd. has submitted to the Exchange a copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended June 2009". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.29 Jul · Raising of Funds
Cipla Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on July 29, 2009 inter-alia approved the notice convening Annual General Meeting including an enabling resolution to raise funds upto Rs. 1500 crores subject to shareholders and other necessary approvals by further issue of securities in domestic/international markets through various instruments including equity shares/warrants with Non-Convertible Debentures under Qualified Institutions Placement (QIP) or Foreign Currency Convertible Bonds (FCCBs) or American Depository Receipts (ADRs) or Global Depository Receipts (GDRs) etc.29 Jul · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 132526 lacs for quarter ending on 30-JUN-2009 against Rs. 120712 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 24171 lacs for the quarter ending on 30-JUN-2009 against Rs. 14004 lacs for the quarter ending on 30-JUN-2008.21 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009/Unaudited Financial Results/Raising of funds/Others”15 Jul · Updates
Cipla Ltd. has submitted to the Exchange a copy of the Abstract of Audited Financial Results of the Company for the year ended March 31, 2009 as required under Clause 20 of the Listing Agreement. It has been approved at the meeting of the Board of Directors of the Company held on July 15, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Jul · Corporate action
Cipla Ltd. has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from August 12, 2009 to August 26, 2009 (both days inclusive) for the purpose of Annual General Meeting and determining the persons entitled for dividend for the year ended March 31, 2009.15 Jul · Dividend
Cipla Ltd. has informed the Exchange that the Directors at their meeting held on July 15, 2009 has recommended payment of dividend of Rs.2 per equity share (face value Rs.2) for the year 2008-2009 amounting to Rs.155.46 crores.15 Jul · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 496060 lacs for year ending on 31-MAR-2009 against Rs. 421845 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 77682 lacs for the year ending on 31-MAR-2009 against Rs. 70143 lacs for the year ending on 31-MAR-2008.15 Jul · Results
Cipla Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 496060 lacs for year ending on 31-MAR-2009 against Rs. 423093 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 77102 lacs for the year ending on 31-MAR-2009 against Rs. 70104 lacs for the year ending on 31-MAR-2008.9 Jul · Updates
Cipla Ltd. has informed the Exchange that "This has reference to our earlier disclosures regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India. The Company has now received further demand notices from the Government as under: (i) demand notice demanding an amount of Rs. 64.39 crores comprising allegedly overcharged amount of Rs 43.29 crores and interest thereon of Rs. 21.10 crores upto June 2009 in respect of the drug Salbutamol. (ii) demand notice demanding an amount of Rs. 2.19 crores comprising allegedly overcharged amount of Rs 1.45 crores for the period October 2005 to March 2006 and interest thereon of Rs. 0.74 crores upto June 2009 in respect of the drug Norfloxacin.These demands are contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable".7 Jul · Board meeting
Inter-alia to consider the Annual Audited Accounts for the year ended March 31, 2009 and Recommendation of Dividend, if any.
May 2009
13 May · Updates
Cipla Ltd. has informed the Exchange that: "Oseltamivir 75mg capsules marketed as "Antiflu" by the Company has been included in the World Health Organisation (WHO) list of Prequalified Medicinal Products. Oseltamivir is indicated for use in the treatment of influenza A (H1N1) infection commonly known as swine flu".5 May · Updates
Cipla Ltd. has informed the Exchange that "United States Food and Drug Administration (US FDA) has granted tentative approval for tenofovir disoproxil fumarate tablets, 300mg, manufactured by the company under the President's Emergency Plan for AIDS Relief ( PEPFAR ) program. Tenofovir disoproxil fumarate tablets are indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults".
Apr 2009
24 Apr · Updates
Cipla Ltd. has submitted to the Exchange a revised copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended March 2009". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Apr · Updates
Cipla Ltd. has submitted to the Exchange a copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended March 2009". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Apr · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 123517 lacs for quarter ending on 31-MAR-2009 against Rs. 112210 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 25292 lacs for the quarter ending on 31-MAR-2009 against Rs. 17945 lacs for the quarter ending on 31-MAR-2008.16 Apr · Board meeting
Meeting on 24 Apr 2009: “Unaudited Financial Results for the qtr ended March 31, 2009”
Jan 2009
23 Jan · Updates
Cipla Ltd. has informed the Exchange that: "Credit Analysis and Research Limited (CARE) has assigned a 'CARE AAA / PR1+' rating to the various bank facilities for an aggregate amount of Rs. 1734.50 crores and 'PR1+' rating to the Proposed Term Loan / Non Convertible Debentures (NCD) / Commercial Paper (CP) of the Company for an amount of Rs.500 crores".22 Jan · Updates
Cipla Ltd. has submitted to the Exchange a copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended December 2008". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jan · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 126430 lacs for quarter ending on 31-DEC-2008 against Rs. 110449 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 22344 lacs for the quarter ending on 31-DEC-2008 against Rs. 21065 lacs for the quarter ending on 31-DEC-2007.14 Jan · Board meeting
Meeting on 22 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
22 Oct · Updates
Cipla Ltd. has submitted to the Exchange a copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended September 2008" A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Oct · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 247322 lacs for half year ending on 30-SEP-2008 against Rs. 200022 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 29147 lacs for the half year ending on 30-SEP-2008 against Rs. 31038 lacs for the half year ending on 30-SEP-2007.22 Oct · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 130246 lacs for quarter ending on 30-SEP-2008 against Rs. 109839 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 15143 lacs for the quarter ending on 30-SEP-2008 against Rs. 19062 lacs for the quarter ending on 30-SEP-2007.14 Oct · Board meeting
Meeting on 22 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Sep 2008
1 Sep · Meeting
Cipla Ltd. has informed the Exchange that at the Annual General Meeting of the Company held on August 28, 2008, all resolutions were passed unanimously. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
13 Aug · Updates
Cipla Ltd. has informed the Exchange that dividend warrants for the year 2007-2008 will be dated on or about September 04, 2008 and will be dispatched to the shareholders within the stipulated time limit.4 Aug · Meeting
Cipla Ltd. has informed the Exchange that the Annual General Meeting of the Company will be held on August 28, 2008.
Jul 2008
18 Jul · Corporate action
Cipla Ltd. has informed the Exchange that the Company has announce the Book Closure from August 14, 2008 to August 28, 2008 for the purpose of dividend. Further the dividend is payable on or before September 27, 2008.18 Jul · Updates
Cipla Ltd. has submitted to the Exchange a copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended June 2008" A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jul · Updates
Cipla Ltd. has submitted to the Exchange a copy of Abstract of Audited Financial Results of the Company for the year ended March 31, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.18 Jul · Results
Cipla Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 423093 lacs for year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 70104 lacs for the year ending on 31-MAR-2008.18 Jul · Dividend
Cipla Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on July 18, 2008 recommended payment of dividend of Rs.2 per equity share (face value Rs.2) for the year 2007-2008 amounting to Rs.155.46 crores.18 Jul · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 421845 lacs for year ending on 31-MAR-2008 against Rs. 357071 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 70143 lacs for the year ending on 31-MAR-2008 against Rs. 66803 lacs for the year ending on 31-MAR-2007.18 Jul · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 120712 lacs for quarter ending on 30-JUN-2008 against Rs. 90183 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 14004 lacs for the quarter ending on 30-JUN-2008 against Rs. 11976 lacs for the quarter ending on 30-JUN-2007.10 Jul · Board meeting
Inter-alia to consider the Annual Accounts for the year ended March 31, 2008, Recommendation of Dividend, if any and Unaudited Financial Results for first quarter ended June 30, 2008.
Apr 2008
25 Apr · Updates
Cipla Ltd. has submitted to the exchange a copy of the note displayed on Company's website www.cipla.com titled "Financial Review- Period ended March 2008" A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Apr · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 422681 lacs for year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 70048 lacs for the year ending on 31-MAR-2008.25 Apr · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 112210 lacs for quarter ending on 31-MAR-2008 against Rs. 93847 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 17945 lacs for the quarter ending on 31-MAR-2008 against Rs. 12573 lacs for the quarter ending on 31-MAR-2007.17 Apr · Board meeting
Meeting on 25 Apr 2008: “Unaudited Financial Results for the qtr ended March 31, 2008”
Mar 2008
24 Mar · Updates
Cipla Ltd. had informed the Exchange about various disclosures made to Stock Exchanges regarding notices received by the Company from the National Pharmaceutical Pricing Authority, Government of India. The Company has now received further demand notices from the Government demanding an amount of Rs.62.85 crores towards interest for the period April 2007 to January 2008 on alleged overcharged amounts in respect of the drugs Ciprofloxacin, Norfloxacin, Salbutamol and Theophylline. The NPPA has also made a fresh demand of Rs. 4.12 crores as alleged overcharged amounts inclusive of interest in respect of the drug Doxycycline and additional packs of the drug Norfloxacin. The demand is contrary to the orders of the Hon'ble Supreme Court of India and the Company has received legal advice that entire amounts demanded by the Government are not tenable and sustainable.5 Mar · Management
Cipla Ltd. has informed the Exchange that the Board of Directors at its meeting held on March 5, 2008 appointed Mr. Pankaj Patel as a Director in casual vacancy with effect from 5th March,2008.
Jan 2008
24 Jan · Updates
Cipla Ltd. has submitted to the exchange a copy of the note displayed on Company website WWW.cipla.com titled "Financial Review- Period ended December 2007" A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.24 Jan · Results
Cipla Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 110449 lacs for quarter ending on 31-DEC-2007 against Rs. 88054 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 21065 lacs for the quarter ending on 31-DEC-2007 against Rs. 18438 lacs for the quarter ending on 31-DEC-2006.